Author:
Bharitkar Yogesh P.,Kanhar Satish,Suneel Neradibilli,Mondal Susanta Kumar,Hazra Abhijit,Mondal Nirup B.
Publisher
Springer Science and Business Media LLC
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Drug Discovery,Molecular Biology,General Medicine,Information Systems,Catalysis
Reference39 articles.
1. Lavie D, Glotter E, Shvo Y (1965) Constituents of Withania somnifera Dun: III. The side chain of withaferin A. J Org Chem 30:1774–1778. doi: 10.1021/jo01017a015
2. Mohan R, Hammers HJ, Bargagna-Mohan P, Zhan XH, Herbstritt CJ, Ruiz A, Zhang L, Hanson AD, Conner BP, Rougas J, Pribluda VS (2004) Withaferin A is a potent inhibitor of angiogenesis. Angiogenesis 7:115–122
3. Yokota Y, Bargagna-Mohan P, Ravindranath PP, Kim KB, Mohan R (2006) Development of withaferin A analogs as probes of angiogenesis. Bioorg Med Chem Lett 16:2603–2607. doi: 10.1016/j.bmcl.2006.02.039
4. Kumar PS, Shilpa P, Salimath BP (2009) Withaferin A suppresses the expression of vascular endothelial growth factor in Ehrlich ascites tumor cells via Sp1 transcription factor. Curr Trends Biotechnol Pharm 3:138–148
5. Jilani K, Lupescu A, Zbidah M, Shaik N, Lang F (2013) Withaferin A-stimulated $$\text{ Ca }^{2+}$$ Ca 2 + entry, ceramide formation and suicidal death of erythrocytes. Toxicol Vitro 27:52–58. doi: 10.1016/j.tiv.2012.09.004
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献